Monte Rosa Therapeutics (GLUE) FCF Margin (2024 - 2026)
Monte Rosa Therapeutics' FCF Margin came in at -544.57% for Q2 2026, down 387.57 percentage points from -157.00% a year earlier but up 387.43 percentage points from the prior quarter.
Powered by 
Analysis
Monte Rosa Therapeutics (GLUE) FCF Margin (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Monte Rosa Therapeutics reported FCF Margin of -111.66%, down 125.07 percentage points year-over-year; for FY2025, it was -22.23%, down 72.50 percentage points from FY2024.
- Going back by year, FCF Margin was 50.26% in FY2024.
- The five-year range for quarterly FCF Margin is -3717.01% (Q1 2024) to 781.46% (Q3 2025).
- Year-over-year, FCF Margin has declined for three consecutive quarters, with an average year-over-year change of +350.33 percentage points over the last six quarters.
- Business Quant data shows GLUE's FCF Margin at -932.00% (Q1 2026), -1574.29% (Q4 2025) and 781.46% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 30.39% |
| 10 | Monte Rosa Therapeutics | 1.00 Bn | 412.37 Mn | - | -544.57% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -544.57% |
| Mar 31, 2026 | -932.00% |
| Dec 31, 2025 | -1,574.29% |
| Sep 30, 2025 | 781.46% |
| Jun 30, 2025 | -157.00% |
| Mar 31, 2025 | -55.43% |
| Dec 31, 2024 | 212.28% |
| Sep 30, 2024 | -232.13% |
| Jun 30, 2024 | -634.48% |
| Mar 31, 2024 | -3,717.01% |
API Access
Monte Rosa Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=GLUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "GLUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=GLUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();